FAFTFSNP
Fjarde AP-fonden (The Fourth Swedish National Pensionfund) Portfolio holdings
AUM
$8.86B
1 Year Est. Return
–
AUM
$8.86B
AUM Growth
–
Holding
539
Top Buys
| 1 | +$548M | |
| 2 | +$545M | |
| 3 | +$545M | |
| 4 |
Amazon
AMZN
|
+$290M |
| 5 |
Meta Platforms (Facebook)
META
|
+$222M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 34.53% |
| 2 | Healthcare | 14.23% |
| 3 | Financials | 13.52% |
| 4 | Communication Services | 10.32% |
| 5 | Consumer Discretionary | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
McDonald's
MCD
$213B
| $58M | 0.65% |
+227,570
|
|
||
27
Netflix
NFLX
$463B
| $57M | 0.64% |
+84,486
|
|
||
28
Texas Instruments
TXN
$144B
| $55.1M | 0.62% |
+283,031
|
|
||
29
Verizon
VZ
$165B
| $54.6M | 0.62% |
+1,325,082
|
|
||
30
Adobe
ADBE
$140B
| $54.2M | 0.61% |
+97,623
|
|
||
31
IBM
IBM
$281B
| $48.6M | 0.55% |
+281,181
|
|
||
32
Accenture
ACN
$150B
| $46.8M | 0.53% |
+154,358
|
|
||
33
Qualcomm
QCOM
$189B
| $46.5M | 0.53% |
+233,634
|
|
||
34
Amgen
AMGN
$160B
| $46.2M | 0.52% |
+147,762
|
|
||
35
Bank of America
BAC
$391B
| $45.3M | 0.51% |
+1,139,470
|
|
||
36
Applied Materials
AMAT
$186B
| $42.6M | 0.48% |
+180,672
|
|
||
37
Advanced Micro Devices
AMD
$410B
| $42.2M | 0.48% |
+260,202
|
|
||
38
Oracle
ORCL
$710B
| $41.6M | 0.47% |
+294,668
|
|
||
39
Salesforce
CRM
$243B
| $39.2M | 0.44% |
+152,555
|
|
||
40
Pfizer
PFE
$138B
| $38.4M | 0.43% |
+1,370,671
|
|
||
41
Comcast
CMCSA
$99.3B
| $36.9M | 0.42% |
+942,791
|
|
||
42
Intuit
INTU
$183B
| $36.8M | 0.42% |
+56,040
|
|
||
43
Caterpillar
CAT
$259B
| $36.7M | 0.41% |
+110,146
|
|
||
44
Vertex Pharmaceuticals
VRTX
$110B
| $33.4M | 0.38% |
+71,188
|
|
||
45
Thermo Fisher Scientific
TMO
$212B
| $33.3M | 0.38% |
+60,265
|
|
||
46
Wells Fargo
WFC
$274B
| $33.2M | 0.38% |
+559,845
|
|
||
47
GE Aerospace
GE
$322B
| $33.2M | 0.37% |
+208,565
|
|
||
48
Blackrock
BLK
$164B
| $33.1M | 0.37% |
+42,061
|
|
||
49
Marsh & McLennan
MMC
$87.5B
| $31.2M | 0.35% |
+148,031
|
|
||
50
Regeneron Pharmaceuticals
REGN
$66.3B
| $30.7M | 0.35% |
+29,252
|
|